vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $403.4M, roughly 1.6× Madison Square Garden Sports Corp.). Natera, Inc. runs the higher net margin — 7.1% vs 2.0%, a 5.1% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 12.8%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $31.6M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -3.1%).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

MSGS vs NTRA — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.6× larger
NTRA
$665.5M
$403.4M
MSGS
Growing faster (revenue YoY)
NTRA
NTRA
+27.0% gap
NTRA
39.8%
12.8%
MSGS
Higher net margin
NTRA
NTRA
5.1% more per $
NTRA
7.1%
2.0%
MSGS
More free cash flow
NTRA
NTRA
$6.2M more FCF
NTRA
$37.8M
$31.6M
MSGS
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-3.1%
MSGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSGS
MSGS
NTRA
NTRA
Revenue
$403.4M
$665.5M
Net Profit
$8.2M
$47.3M
Gross Margin
Operating Margin
5.5%
-3.4%
Net Margin
2.0%
7.1%
Revenue YoY
12.8%
39.8%
Net Profit YoY
641.9%
187.9%
EPS (diluted)
$0.34
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
NTRA
NTRA
Q4 25
$403.4M
$665.5M
Q3 25
$39.5M
$592.2M
Q2 25
$204.0M
$546.6M
Q1 25
$424.2M
$501.8M
Q4 24
$357.8M
$476.1M
Q3 24
$53.3M
$439.8M
Q2 24
$227.3M
$413.4M
Q1 24
$430.0M
$367.7M
Net Profit
MSGS
MSGS
NTRA
NTRA
Q4 25
$8.2M
$47.3M
Q3 25
$-8.8M
$-87.5M
Q2 25
$-1.8M
$-100.9M
Q1 25
$-14.2M
$-66.9M
Q4 24
$1.1M
$-53.8M
Q3 24
$-7.5M
$-31.6M
Q2 24
$25.5M
$-37.5M
Q1 24
$37.9M
$-67.6M
Operating Margin
MSGS
MSGS
NTRA
NTRA
Q4 25
5.5%
-3.4%
Q3 25
-69.5%
-16.5%
Q2 25
-11.1%
-20.2%
Q1 25
7.6%
-15.8%
Q4 24
3.7%
-13.6%
Q3 24
-15.5%
-8.9%
Q2 24
23.0%
-10.6%
Q1 24
18.5%
-20.2%
Net Margin
MSGS
MSGS
NTRA
NTRA
Q4 25
2.0%
7.1%
Q3 25
-22.3%
-14.8%
Q2 25
-0.9%
-18.5%
Q1 25
-3.4%
-13.3%
Q4 24
0.3%
-11.3%
Q3 24
-14.1%
-7.2%
Q2 24
11.2%
-9.1%
Q1 24
8.8%
-18.4%
EPS (diluted)
MSGS
MSGS
NTRA
NTRA
Q4 25
$0.34
$0.36
Q3 25
$-0.37
$-0.64
Q2 25
$-0.08
$-0.74
Q1 25
$-0.59
$-0.50
Q4 24
$0.05
$-0.41
Q3 24
$-0.31
$-0.26
Q2 24
$1.07
$-0.30
Q1 24
$1.57
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$81.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-282.1M
$1.7B
Total Assets
$1.5B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
NTRA
NTRA
Q4 25
$81.3M
Q3 25
$48.6M
$1.0M
Q2 25
$144.6M
$16.0M
Q1 25
$96.5M
$17.8M
Q4 24
$107.8M
$22.7M
Q3 24
$52.3M
$29.5M
Q2 24
$89.1M
$90.3M
Q1 24
$40.0M
$69.1M
Stockholders' Equity
MSGS
MSGS
NTRA
NTRA
Q4 25
$-282.1M
$1.7B
Q3 25
$-294.2M
$1.3B
Q2 25
$-281.4M
$1.2B
Q1 25
$-283.4M
$1.2B
Q4 24
$-273.1M
$1.2B
Q3 24
$-277.5M
$878.5M
Q2 24
$-266.3M
$836.5M
Q1 24
$-294.0M
$794.1M
Total Assets
MSGS
MSGS
NTRA
NTRA
Q4 25
$1.5B
$2.4B
Q3 25
$1.5B
$1.8B
Q2 25
$1.5B
$1.8B
Q1 25
$1.5B
$1.7B
Q4 24
$1.4B
$1.7B
Q3 24
$1.4B
$1.6B
Q2 24
$1.3B
$1.5B
Q1 24
$1.4B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
NTRA
NTRA
Operating Cash FlowLast quarter
$32.4M
$73.9M
Free Cash FlowOCF − Capex
$31.6M
$37.8M
FCF MarginFCF / Revenue
7.8%
5.7%
Capex IntensityCapex / Revenue
0.2%
5.4%
Cash ConversionOCF / Net Profit
3.94×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
NTRA
NTRA
Q4 25
$32.4M
$73.9M
Q3 25
$-85.0M
$59.4M
Q2 25
$49.7M
$37.6M
Q1 25
$6.3M
$44.5M
Q4 24
$61.8M
$52.9M
Q3 24
$-26.2M
$51.8M
Q2 24
$108.4M
$4.0M
Q1 24
$4.0M
$27.0M
Free Cash Flow
MSGS
MSGS
NTRA
NTRA
Q4 25
$31.6M
$37.8M
Q3 25
$-85.3M
$37.0M
Q2 25
$49.4M
$11.7M
Q1 25
$3.9M
$22.6M
Q4 24
$61.2M
$34.8M
Q3 24
$-26.5M
$35.5M
Q2 24
$108.0M
$-7.7M
Q1 24
$3.9M
$6.7M
FCF Margin
MSGS
MSGS
NTRA
NTRA
Q4 25
7.8%
5.7%
Q3 25
-216.3%
6.2%
Q2 25
24.2%
2.1%
Q1 25
0.9%
4.5%
Q4 24
17.1%
7.3%
Q3 24
-49.7%
8.1%
Q2 24
47.5%
-1.9%
Q1 24
0.9%
1.8%
Capex Intensity
MSGS
MSGS
NTRA
NTRA
Q4 25
0.2%
5.4%
Q3 25
0.9%
3.8%
Q2 25
0.2%
4.7%
Q1 25
0.6%
4.3%
Q4 24
0.1%
3.8%
Q3 24
0.7%
3.7%
Q2 24
0.2%
2.8%
Q1 24
0.0%
5.5%
Cash Conversion
MSGS
MSGS
NTRA
NTRA
Q4 25
3.94×
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
55.61×
Q3 24
Q2 24
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons